Study on Sit to Quit Phone Intervention

• Status: Enrolling by invitation
• Trial end date: 0000-00-00
• Target enrollment: 60
• Participant gender: Both

Summary

This study is designed to test the effectiveness of the smoking cessation intervention "Sit to Quit" through a randomized-control trial. This study will compare abstinence outcomes in the Sit to Quit study group to a control group using the North Carolina State Tobacco Quit Line.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Collaborators: Alere Wellbeing; National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine
• Last Updated: 2016-09-19

Criteria

Inclusion Criteria:

• Patient being treated at Duke Smoking Cessation Program for tobacco use

• Age 18 years or older

• Actively smoking 5 or more cigarettes per day for at least one year

• Fluency in spoken and written English

• Willing to set a quit date within 2 weeks

• Access to a smart phone or internet and telephone

• Willingness to watch 3 videos on computer, receive 5 counseling calls, and attend investigational visits.

• Willingness to use Nicotine Patch.

Exclusion Criteria:

• CO test under 7 ppm during initial screening

• 8 or above on the Alcohol Use Disorders Identification Test (AUDIT-10)

• 6 or above on Drug Abuse Screening Test (DAST-10)

• 3 or above on Patient Health Questionnaire (PHQ-2) Depression Scale

• Daily use of a second form of tobacco or nicotine (e.g. e-cigarettes, cigars, chewing tobacco, snuff)

• Current use of a smoking cessation medication (e.g. nicotine replacement, Varenicline, Bupropion)

• Intolerable side effects related to, refusal to take, or medical contraindication with nicotine patch

• Symptomatic cognitive or emotive disorder such as untreated schizophrenia, severe untreated depression, or severe untreated anxiety. This is determined by clinical assessment.

• Report of pregnancy, attempting to get pregnant, or actively breast feeding.

• Positive urine pregnancy test (only given to females with child bearing potential)